Atlas Trials

Thyroid Dysfunction Induced by Anti-PD-1 Therapy in Patients With Advanced Carcinoma

Clinical trial NCT05593744 · COMPLETED

Trial details

NCT number
NCT05593744
Sponsor
Qilu Hospital of Shandong University
Status
COMPLETED
Study type
OBSERVATIONAL
Carcinoma
Start date
2020-08-17
Primary completion
2022-03-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.